FGFR2: A pan-genomic target.

Russell Madison,Ethan Sokol,Alexa Betzig Schrock,Adrienne Johnson,Dean Pavlick,Julia Andrea Elvin,Jo-Anne Vergilio,Nhu Ngo,Jonathan Keith Killian,Douglas I. Lin,Shakti H. Ramkissoon,Eric Allan Severson,Amanda Hemmerich,Daniel Duncan,Siraj M. Ali,Prasanth Reddy,Kimberly McGregor,Brian M. Alexander,Vincent A. Miller,Jeffrey S. Ross

FGFR2: A pan-genomic target.

2019

3099Background: FGFR2 genomic alterations (GA) have been described in a variety of solid tumors and emerged as biomarkers for investigational agents undergoing clinical trials. Methods: 201,766 pri...

Keywords:

Pathology
Medicine
Bioinformatics
INVESTIGATIONAL AGENTS
Biomarker (medicine)
Clinical trial
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations